For innovation to transform health outcomes for people around the world, new treatments, devices, and technologies must be accessible, inclusive, and designed with the needs of patients and communities in mind. However, many patient populations are less represented in clinical trials, limiting the broader applicability of the research.1
Barriers to trial participation are multifaceted and can include restrictive or noninclusive study design, logistical burdens, and a lack of scalable approaches to support investigator and site readiness in resource-limited communities.2 Expanding local research capability through innovative solutions may help reduce barriers to participation, including by making clinical trials closer to where patients live.
To help patients around the world living with immune diseases participate in clinical research, Johnson & Johnson launched the Expanding Access to Immunology Clinical Trials QuickFire Challenge.
Awards:- Innovators are invited to submit ideas for tools, platforms, or technologies with the goal to improve outreach, enrollment, and retention of participants in clinical trials focused on immune diseases in resource-limited communities. The innovators with the most promising potential solutions aligned to this QuickFire Challenge will have the opportunity to receive award funding from a total pool of up to $350,000.*
Deadline:- 18-09-2026
